Tranzactioneaza Metlife Inc (US.MET) - 78.21 USD (%) Tranzactioneaza

Cramer’s lightning round: Enbridge is a buy

Blackline Inc (US.BL): “They’re losing money. ... We can just not go with it.&nbsp

Enbridge Inc (US.ENB): “That is exactly what you should be buying.”

AxoGen Inc (US.AXGN): “It’s a medical device, and I think you have to stick with tried and true. .. Johnson &amp Johnson.”&nbsp

MetLife Inc (US.MET): “I’m going to have to say yes to that, even as I’m not a great fan of the insurers. ... That is too cheap a stock.”&nbsp

Bridge Investment Group Holdings: “We don’t really know what they do. ... Pass, because there’s too much room for error.”&nbsp

Farfetch Ltd (US.FTCH): “I say, buy Target down here.”

cramers lightning round enbridge is a buy 2022

MetLife’s (US.MET) Earnings Surge, but Covid-19 Limits Insurer’s Latest Results

High levels of Covid-19 deaths hurt fourth-quarter results in MetLife Inc.’s business of providing employer-sponsored life insurance as the Delta variant persisted in the U.S., but the outsize payouts were more than offset by unusually strong investment gains. The New York company’s net income soared to $1.18 billion, up from $124 million in the year-earlier period, when results were hurt by mark-to-market losses on financial hedges that aim to protect against falling interest rates. MetLife’s adjusted earnings, which analysts track as a measure of recurring profitability, were flat at $1.84 billion.